Dietary intake of vitamin K is inversely associated with mortality risk.

Vitamin K has been related to cardiovascular disease and cancer risk. However, data on total mortality are scarce. The aim of the present study was to assess the association between the dietary intake of different types of vitamin K and mortality in a Mediterranean population at high cardiovascular disease risk. A prospective cohort analysis was conducted in 7216 participants from the PREDIMED (Prevención con Dieta Mediterránea) study (median follow-up of 4.8 y). Energy and nutrient intakes were evaluated using a validated 137-item food frequency questionnaire. Dietary vitamin K intake was calculated annually using the USDA food composition database and other published sources. Deaths were ascertained by an end-point adjudication committee unaware of the dietary habits of participants after they had reviewed medical records and linked up to the National Death Index. Cox proportional hazard models were fitted to assess the RR of mortality. Energy-adjusted baseline dietary phylloquinone intake was inversely associated with a significantly reduced risk of cancer and all-cause mortality after controlling for potential confounders (HR: 0.54; 95% CI: 0.30, 0.96; and HR: 0.64; 95% CI: 0.45, 0.90, respectively). In longitudinal assessments, individuals who increased their intake of phylloquinone or menaquinone during follow-up had a lower risk of cancer (HR: 0.64; 95% CI: 0.43, 0.95; and HR: 0.41; 95% CI: 0.26, 0.64, respectively) and all-cause mortality (HR: 0.57; 95% CI: 0.44, 0.73; and HR: 0.55; 95% CI: 0.42, 0.73, respectively) than individuals who decreased or did not change their intake. Also, individuals who increased their intake of dietary phylloquinone had a lower risk of cardiovascular mortality risk (HR: 0.52; 95% CI: 0.31, 0.86). However, no association between changes in menaquinone intake and cardiovascular mortality was observed (HR: 0.76; 95% CI: 0.44, 1.29). An increase in dietary intake of vitamin K is associated with a reduced risk of cardiovascular, cancer, or all-cause mortality in a Mediterranean population at high cardiovascular disease risk. This trial was registered at http://www.controlled-trials.com as ISRCTN35739639.

[1]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[2]  C. Vermeer,et al.  The role of vitamin K in soft-tissue calcification. , 2012, Advances in nutrition.

[3]  G. Eide,et al.  Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. , 2011, Bone.

[4]  R. Lamuela-Raventós,et al.  A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. , 2011, The Journal of nutrition.

[5]  P. Giriwono,et al.  Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor κB through the repression of IKKα/β phosphorylation. , 2010, The Journal of nutritional biochemistry.

[6]  R. Kaaks,et al.  Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). , 2010, The American journal of clinical nutrition.

[7]  D. van der A,et al.  Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 Diabetes , 2010, Diabetes Care.

[8]  Dolores Corella,et al.  Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain , 2010, British Journal of Nutrition.

[9]  J. Witteman,et al.  A high menaquinone intake reduces the incidence of coronary heart disease. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  M. Kergoat,et al.  Validation of a semi-quantitative food frequency questionnaire measuring dietary vitamin K intake in elderly people. , 2009, Journal of the American Dietetic Association.

[11]  Takeshi Akiyoshi,et al.  The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway , 2009, Cancer Chemotherapy and Pharmacology.

[12]  S. Rohrmann,et al.  Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). , 2008, The American journal of clinical nutrition.

[13]  S. Sasaki,et al.  Vitamin K content of foods and dietary vitamin K intake in Japanese young women. , 2007, Journal of nutritional science and vitaminology.

[14]  T. Aoki,et al.  Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines. , 2006, International journal of molecular medicine.

[15]  S. Booth,et al.  Vitamin k contents of meat, dairy, and fast food in the u.s. Diet. , 2006, Journal of agricultural and food chemistry.

[16]  Yusuke Ohsaki,et al.  Vitamin K Suppresses Lipopolysaccharide-Induced Inflammation in the Rat , 2006, Bioscience, biotechnology, and biochemistry.

[17]  J. Manson,et al.  Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women , 2005, European Journal of Clinical Nutrition.

[18]  A. Hofman,et al.  Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. , 2004, The Journal of nutrition.

[19]  A. Tamori,et al.  Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. , 2004, JAMA.

[20]  D. Lamson,et al.  The anticancer effects of vitamin K. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[21]  M. Shearer,et al.  Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in a national sample of British elderly people , 2002, British Journal of Nutrition.

[22]  L. Schurgers,et al.  Differential lipoprotein transport pathways of K-vitamins in healthy subjects. , 2002, Biochimica et biophysica acta.

[23]  Y. Ouchi,et al.  Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. , 2001, Nutrition.

[24]  W C Willett,et al.  Adjustment for total energy intake in epidemiologic studies. , 1997, The American journal of clinical nutrition.

[25]  B. Carr,et al.  Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin K , 1995, Journal of cellular physiology.

[26]  M. Bots,et al.  Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. , 1995, Atherosclerosis.

[27]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[28]  D. Corella,et al.  COHORT PROFILE Cohort Profile : Design and methods of the PREDIMED study , 2012 .

[29]  José Mataix Verdú,et al.  TABLA DE COMPOSICIÓN DE ALIMENTOS , 2009 .

[30]  F. Hu,et al.  Phylloquinone intake and risk of cardiovascular diseases in men. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  L. Schurgers,et al.  Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. , 2000, Haemostasis.

[32]  G. Colditz,et al.  Vitamin K intake and hip fractures in women: a prospective study. , 1999, The American journal of clinical nutrition.

[33]  F. Wu,et al.  Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. , 1993, Life sciences.

[34]  M. Martínez-González,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .